Vaccitech
Vaccitech Inc. is a private biotechnology company developing bio-technologies for large-scale vaccine production targeting infectious diseases, with a stated B2B go-to-market aimed at healthcare systems, governments, and pharmaceutical companies.
- Company typePrivate
- Founded-
- HeadquartersCity Of Industry, United States
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What Vaccitech does
Vaccitech Inc. is a private biotechnology company that develops bio-technologies intended for large-scale vaccine production targeting infectious diseases. The company characterizes its offering as high-impact biotechnology designed to "revolutionize" vaccine production processes, with a stated mission to transform global population health through improved vaccine accessibility. Its go-to-market is described as direct B2B sales to healthcare systems, governments, and pharmaceutical companies globally.
The company's product surface is narrow and broadly defined: a single offering labeled "Vaccine Production Technology," positioned around the tagline "THE FUTURE OF MASS VACCINE PRODUCTION." The source data provides no underlying technical specification — no mechanism of action (e.g., cell-line engineering, fermentation/bioprocess platform, viral vector system, mRNA platform), no patents or trademarks, no peer-reviewed validation, and no certifications or regulatory milestones are disclosed. Public-facing communication is limited to a sparse homepage (predominantly image placeholders), a Facebook page, and a Twitter account.
Operationally, the company presents material ambiguities. Firmographic records list "City of Industry, United States," while a separate data block and the company website list headquarters in Monterrey, Mexico with contact number +52 (81) 4593-0739. The firmographic profile indicates 1–10 employees, no disclosed funding history, no named management team, no disclosed revenue or pricing, no named customers, and no listed partnerships. Business model mechanics — pricing, contract structure, revenue recognition — are not disclosed.
Vaccitech firmographics
Firmographics- Name
- Vaccitech
- Legal name
- Vaccitech Inc.
- Website
- https://vaccitech.com
- Company type
- Private
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Vaccitech Inc. is a private biotechnology company developing bio-technologies for large-scale vaccine production targeting infectious diseases, with a stated B2B go-to-market aimed at healthcare systems, governments, and pharmaceutical companies.
- Ownership category
- akta.pro rank
Vaccitech industry classification
Industry- Product category
- Vaccine Production Technology
- NAICS
- Biological Product (except Diagnostic) Manufacturing (325414), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- SIC
- Biological Products, (No Disgnostic Substances) (2836)
- akta.pro primary industry
- Vaccine Technology Platforms (mRNA, viral vector, protein subunit, inactivated/live-attenuated, VLP, DNA) (HLAAAEAD)
- akta.pro secondary industry
- Infectious Disease & Pandemic Preparedness Vaccines (emerging pathogens) (HLAAAEAC)
Keywords
Where Vaccitech is headquartered
LocationHeadquarters
- HQ city
- City Of Industry
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Vaccitech business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Operations, Marketing or Sales
Distribution channels1 record
Marketing channels2 records
Vaccitech product offering
Product offeringCore offering
Vaccitech Inc. is a biotechnology company that designs high-impact bio-technologies to revolutionize large-scale vaccine production processes for infectious diseases. The company's core offering centers on vaccine production technology aimed at radically transforming global population health through improved vaccine accessibility and mass production capabilities.
Product overview
Vaccitech is a single-product biotechnology company focused on vaccine production technology. The company designs high-impact bio-technologies that revolutionize large-scale vaccine production processes for infectious diseases. The core offering consists of vaccine production technologies, as indicated by their tagline 'THE FUTURE OF MASS VACCINE PRODUCTION' and their stated mission to radically transform global population health through improved vaccine accessibility.
Differentiator
Problem solved
Functional benefit
Products and services
- Vaccine Production Technology
Companies that use Vaccitech
Customer profileSegments1 record
Ideal customer profiles1 record
Vaccitech technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Vaccitech partnerships and signals
Strategic signalExpansion highlights2 records
Vaccitech competitors and assessment
Company assessmentDirect peers
- BioNTech: mRNA vaccine technology company that scaled mass production for COVID-19 and is expanding its infectious-disease pipeline. Comparable as a vaccine technology platform serving infectious diseases at industrial scale.
- Emergent BioSolutions: Specialty vaccine manufacturer focused on infectious disease and public health threats, with both product and contract manufacturing offerings. Directly comparable to Vaccitech's positioning around mass vaccine production for infectious diseases.
- Novavax: Vaccine developer using recombinant protein nanoparticle technology, with a focus on infectious-disease vaccines at scale. Comparable as a platform-based vaccine company targeting mass production for global public health.
- CureVac: mRNA technology company developing vaccines for infectious diseases with proprietary manufacturing processes. Directly comparable as a platform vaccine technology company focused on production scalability.
- Bavarian Nordic: Biotech focused on vaccines for infectious diseases including smallpox/mpox and other public health threats, with proprietary vaccine production capabilities. Closely comparable in targeting infectious-disease vaccine production at industrial scale.
Emerging players
- Lonza Biologics: Global CDMO providing mammalian and microbial biologics manufacturing services, including vaccine-related production. Comparable on the manufacturing-services axis of the vaccine production value chain.
- VBI Vaccines: Smaller-cap vaccine developer with proprietary enveloped virus-like particle technology targeting infectious diseases. Comparable as a small platform vaccine technology company seeking to scale production.
Broad incumbents
- Moderna: Leading mRNA vaccine company with massive manufacturing infrastructure and broad infectious-disease pipeline. Comparable as the dominant scale player in the same vaccine-technology-platform category.
- Sanofi Pasteur: Vaccine division of one of the world's largest vaccine manufacturers, with established large-scale production capabilities across many infectious-disease vaccines. Comparable as an incumbent in the mass vaccine production space.
- GSK Vaccines: Major global vaccine manufacturer with extensive portfolio and large-scale production capabilities across infectious diseases. Comparable as a dominant incumbent in mass vaccine production.
Market position
Strengths3 records
Weaknesses4 records
Competitive moat1 record
Key risks6 records
Key highlights4 records
Customer concentration
Vaccitech social profiles
Digital presenceVaccitech financial estimates
Financial estimateRevenue estimate
Valuation estimate
Vaccitech leadership team
Management profileNumber of profiles
Vaccitech funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Vaccitech M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Vaccitech
What does Vaccitech do?
Vaccitech Inc. is a biotechnology company that designs high-impact bio-technologies to revolutionize large-scale vaccine production processes for infectious diseases. The company's core offering centers on vaccine production technology aimed at radically transforming global population health through improved vaccine accessibility and mass production capabilities.
Is Vaccitech a public or private company?
Vaccitech is a private company. It is classified as unknown and is currently operating.
When was Vaccitech founded?
Vaccitech was founded in -1. It employs 1 to 10 people.
Where is Vaccitech based?
Vaccitech is headquartered in City Of Industry, United States, in the North America region.
Who are Vaccitech's main competitors?
Direct peers on record are BioNTech, Emergent BioSolutions, Novavax, CureVac and Bavarian Nordic. Emerging players are Lonza Biologics and VBI Vaccines. Broad incumbents are Moderna, Sanofi Pasteur and GSK Vaccines.
Does Vaccitech have an API?
No public API is recorded for Vaccitech.
What industry is Vaccitech in?
Vaccitech's product category is Vaccine Production Technology. Its primary akta.pro industry code is HLAAAEAD, Vaccine Technology Platforms (mRNA, viral vector, protein subunit, inactivated/live-attenuated, VLP, DNA), with a secondary code of HLAAAEAC, Infectious Disease & Pandemic Preparedness Vaccines (emerging pathogens). Its NAICS code is 325414 and its SIC code is 2836.